Evidence map›Paper›PMID 25550840›Full record

ArticleInternational journal of clinical and experimental pathology2014

Blood vessel invasion and other variables as predictors of long-term survival in Japanese and British patients with primary invasive breast cancer.

Takao Kato, Francesco Pezzella, Graham Steers, Leticia Campo, Russell D Leek, Helen Turley, Shingo Kameoka, Toshio Nishikawa, Adrian L Harris, Kevin C Gatter and 1 more

Abstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Takao KatoDepartment of Surgery II, School of Medicine, Tokyo Women's Medical University 8-1 Kawadacho, Shinjuku-ku, Tokyo 162-8666, Japan ; Cancer Research UK, Tumor Pathology Group, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital Headington, Oxford, OX3 9DU, UK.
Francesco PezzellaCancer Research UK, Tumor Pathology Group, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital Headington, Oxford, OX3 9DU, UK.
Graham SteersCancer Research UK, Tumor Pathology Group, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital Headington, Oxford, OX3 9DU, UK.
Leticia CampoCancer Research UK, Tumor Pathology Group, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital Headington, Oxford, OX3 9DU, UK.
Russell D LeekCancer Research UK, Tumor Pathology Group, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital Headington, Oxford, OX3 9DU, UK.
Helen TurleyCancer Research UK, Tumor Pathology Group, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital Headington, Oxford, OX3 9DU, UK.
Shingo KameokaDepartment of Surgery II, School of Medicine, Tokyo Women's Medical University 8-1 Kawadacho, Shinjuku-ku, Tokyo 162-8666, Japan.
Toshio NishikawaDepartment of Surgical Pathology, School of Medicine, Tokyo Women's Medical University 8-1 Kawadacho, Shinjuku-ku, Tokyo 162-8666, Japan.
Adrian L HarrisCancer Research UK Molecular Oncology Laboratory, Institute of Molecular Medicine, John Radcliffe Hospital Headington, Oxford, OX3 9DU, UK.
Kevin C GatterCancer Research UK, Tumor Pathology Group, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital Headington, Oxford, OX3 9DU, UK.
Stephen FoxDepartment of Pathology, Peter MacCallum Cancer Center, University of Melbourne Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study was undertaken to investigate the associations of blood vessel invasion (BVI), lymphatic vessel invasion (LVI) or other variables and long-term survival in 173 Japanese and 184 British patients with primary invasive breast cancer, and whether they are associated with survival differences between Japanese and British patients. BVI was detected by objective methods, using both factor VIII-related antigen (F-VIII) staining and elastica van Gieson (E v G) staining. BVI was classified into three subtypes. 1) BVI e, BVI detected by E v G staining alone, 2) BVI f, BVI detected by F-VIII staining alone, 3) BVIef, BVI evaluated by combining BVIf and BVIe. LVI was also detected by objective methods, using lymphatic vessel endothelial hyaluronan receptor-1 (LYVE-1) staining alone. There was a borderline significance between the frequencies for BVIef of British patients and those of Japanese patients (8.2% vs 3.5%; P = 0.06) but not for LVI (P = 0.36). British patients had a significantly worse relapse-free survival (RFS) and overall survival (OS) than Japanese patients (P < 0.01, P < 0.01, respectively) even though their tumors were smaller and more ER-positive with a similar prevalence of lymph-node involvement. LVI was not significantly associated with RFS and OS, however, BVIef positive tumors had a significantly worse RFS and OS compared with BVIef negative patients, after statistical adjustment for the other variables (P = 0.02, P = 0.01, respectively). The present study shows that BVIef variability might contribute to the Japanese and British disparities in breast cancer outcomes.

Indexed as

AdultAgedAged, 80 and overAsian PeopleBiomarkers, TumorBreast NeoplasmsFactor VIIIFemaleHumansJapanLymphatic MetastasisMiddle AgedNeovascularization, PathologicPrognosisSurvival RateUnited KingdomBiomarkers, TumorFactor VIIIblood vessel invasionBreast cancerethnicityKDR/Flk-1lymphatic vessel invasionLYVE-1 staining

Identifiers

PMID25550840
PMCPMC4270576

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.